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Resumen 
El sistema inmune comprende dos clases de respuesta: la respuesta de la 
inmunidad innata y la respuesta de la inmunidad adaptativa. La inmunidad innata es la 
primera línea de defensa contra muchos microorganismos y además dirige el otro tipo 
de respuesta; la respuesta de la inmunidad adaptativa, la cual es un tipo de defensa más 
versátil. En el sistema inmune intestinal, el cual está recibiendo continuamente 
diferentes antígenos; las poblaciones inmunes innatas y adaptativas desempeñan un 
papel crucial para mantener la protección contra infecciones a la vez que evitan una 
respuesta inflamatoria innecesaria. En la primera parte de este trabajo hemos 
investigado el papel de PSGL1, una glicoproteína que se expresa en leucocitos, en la 
regulación de la homeostasis y las respuestas inflamatorias en la lámina propria de 
ratones tratados con DSS para inducir colitis. Hemos observado que en condiciones 
normales los ratones deficientes para PSGL-1 mostraban unas proporciones alteradas de 
poblaciones inmunes innatas y adaptativas, así como macrófagos y células dendríticas 
activadas con presencia de citoquinas proinflamatorias. Se ha descrito previamente que 
PSGL-1 juega un papel en la inducción de un programa tolerogénico en células 
dendríticas, y nosotros confirmamos esto mediante la inducción de una expresión menor 
del complejo mayor de histocompatibilidad clase II (MHC-II) en las células dendríticas 
y macrófagos cuando un anticuerpo anti-PSGL-1, que actúa como agonista de la P-
selectina, es administrado a ratones normales. Además, tras el tratamiento con DSS los 
ratones deficientes en PSGL-1 desarrollan colitis de forma más temprana y severa que 
los ratones control, con un incremento de células Th1 y Th17 además de citoquinas pro-
inflamatorias. Estos resultados apuntan a PSGL-1 como un regulador del balance entre 
respuestas tolerogénicas y protectoras. 
En la segunda parte de este trabajo hemos evaluado la contribución de HDAC6, una 
histona deacetilasa citoplasmática con distintas funciones celulares, en el papel de los 
linfocitos CD8 citotóxicos que contribuyen a la respuesta inmune adaptativa. Se ha 
demostrado que HDAC6 es necesario para la correcta función citolítica de los linfocitos 
T CD8, y que este fenotipo se corresponde con un defecto en la exocitosis. Estudios in 
vivo demuestran que los CTLs deficientes para HDAC6 tienen una menor capacidad 
protectora frente la infección con vaccinia. Cuando se depleciona HDAC6, la señales de 
activación a través del receptor de células T (RCT) y la producción de IFN-ɣ son 
similares a las de un linfocito normal. La monitorización de los gránulos líticos en la 
región proximal, por debajo de la membrana plasmática en la sinapsis inmune, nos ha 
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revelado una dinámica alterada en el transporte de estos gránulos. Finalmente, hemos 
demostrado que HDAC6 interacciona con la kinesina-1 cuando se activa el TCR, y esta 
interacción podría constituir el mecanismo por el cual HDAC6 favorece la eficiencia en 
el transporte terminal de los gránulos líticos hacia el dominio secretor para completar su 
exocitosis. 
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Summary 
The immune system is divided in two types of reactions:  the innate immune 
reactions and the adaptive immune reactions. The innate immunity is the first line of 
defense against many microorganisms; it also drives the subsequent adaptive immune 
reaction which is a more versatile defense. At the intestinal immune system, which is 
continuously challenged by different antigens, the innate and adaptive immune 
populations play a crucial role in maintaining the protection against infection while 
avoid an unnecessary immune response. In the first part of this work, we investigated 
the role of PSGL-1, a glycoprotein expressed in leukocytes, in the regulation of 
homeostasis and inflammatory responses in the lamina propria of DSS-induced colitis 
mice. We found that, at steady state, PSGL-1 knockout mice showed altered proportions 
of innate and adaptive immune population, as well as an activated phenotype of 
macrophages and dendritic cells that mainly produced pro-inflammatory cytokines. Our 
group has previously described that PSGL-1 plays a role in the induction of a 
tolerogenic program in dendritic cells. In the present work, we demonstrated that when 
an anti-PSGL-1 antibody, which acts as an agonist of P-selectin, is administrated to WT 
mice induces a decrease of class II molecule (MHC-II). Moreover, after DSS treatment, 
PSGL-1 deficient mice developed colitis earlier and with higher severity than WT mice, 
with an increment in Th1 and Th17 cells in addition of pro-inflammatory cytokines. 
These results point to PSGL-1 as a key regulator of the balance between tolerogenic and 
protective response. 
On the second part of this work, we assessed the contribution of HDAC6, a cytoplasmic 
histone deacetylase involved in many cellular functions, in the cytotoxic function of 
CD8+ T cells from the adaptive immune response. We demonstrated that HDAC6 is 
needed for the correct cytolytic function of CD8, and this phenotype corresponds to a 
defect in the exocytosis. In vivo studies demonstrated that HDAC6-/- CTLs have a 
reduced protective capacity against vaccinia infection. When HDAC6 is deleted, the 
TCR activation signals and IFN-ɣ production are comparable in HDAC6 deficient and 
WT mice. Monitoring the lytic granules at the proximal region beneath the plasma 
membrane at the immune synapse showed altered dynamics in their transport. Finally, 
we demonstrated that HDAC6 interacts with Kinesin-1 upon TCR activation, and this 
interaction represent a mechanism through which HDAC6 favors the efficient terminal 
transport of lytic granules to their secretory domain in order to complete the exocytosis. 
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1. INTRODUCTION 
 
1.1 PSGL-1: regulatory role at Ulcerative colitis  
The gastro-intestinal tract in humans harbors an estimated number of 1014 
commensal bacteria composed of over 400 species which contribute to the metabolism 
of nutrients. Intestinal immune cells are located in a unique anatomic environment 
intimately associated with the epithelium and continually challenged by a myriad of 
antigens from commensal bacteria, harmful pathogens, nutrients and food antigens that 
force the immune system to continuously balance tolerogenic and protective immune 
response (Coombes & Maloy, 2007; Gross et al, 2015). 
The host has developed a number of mechanisms to discriminate between these 
different stimuli, to ensure the protection against infection while avoiding inflammatory 
response against non-pathogenic antigens (Coombes et al, 2005). Then disruption of this 
delicate balance results in inflammatory reactions, e.g., hyper-reactivity to food 
components or inflammatory bowel diseases (IBDs), such as Crohn´s disease (CD) or 
ulcerative colitis (UC). 
 
1.1.1 Gut structure 
Along the intestine, the surface epithelium is continuously renewed by immature 
cells arising from invaginations known as the crypts of Lieberkuhn, where multipotent 
stem cells give rise to different types of mature epithelial cells. The vast majority of 
these cells are absorptive enterocytes but there are also Paneth cells, goblet cells and 
neuroendocrine cells. The bacteria can be found in the outer but normally do not 
penetrate the inner layer of mucus. The production of mucus is controlled by IFN-γ, IL-
9 and IL-13 (Steenwinckel et al, 2009). This is important because it acts as a physical 
barrier and has toxic effects for many bacteria. In fact, a defect in the mucus synthesis 
increases the penetration of commensal bacteria into the epithelial surface of the colon 
generating enhanced susceptibility to colitis and colon cancer (van der Sluis et al, 2006).  
 
1.1.2 Distribution of immune system in gut 
The lamina propria contains B cells, T cells and numerous innate immune cell 
populations, including DCs, macrophages, eosinophils and mast cells, whereas the 
epithelium primarily contains T cells. The epithelial layer, in addition of acting as a 
barrier, is also involved on the sensing of bacteria mediated by the expression of pattern 
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recognition receptors (Mowat, 2003). Collectively, the intestinal lamina propria and 
epithelium contain the largest population of T cells, plasma cells and macrophages in 
the body (Mowat & Agace, 2014). Although they are separated only by a thin basement 
membrane, the lamina propria and epithelium form very distinct but tightly inter-related 
immunological compartments (Figure 1).  
 
1.1.2.1 Lymphocyte distribution in the intestine 
• Intraepithelial lymphocytes (IELs): They allow the communication with other 
underlying immune cells; in mice there are 10 to 20 fold higher number of IELs 
in the small intestine compared to the colon.  
• Lamina propria T cells: CD4+ and CD8+ T cells that are found in the lamina 
propria supposedly derive from naïve T cells activated in secondary lymphoid 
organs. The CD4+ T cell compartment is diverse, but the distribution of the 
subsets depends in part on variations in the luminal content. In mice, it has been 
observed an inverse correlation between the number of Th17 and Treg cells, 
with a progressively decreasing proportion of Th17 from the duodenum to the 
colon while Tregs are higher in the colon (Denning et al, 2011). Conversely, in 
humans, higher proportions of Th17+ cells are found in the lamina propria of the 
colon. In addition, the frequencies of Th1 and Th2 cells do not vary along the 
human intestine.  
• Intestinal B cells: Lamina propria contains a large number of plasma cells, which 
density reaches its highest at proximal and distal ends of the tract. IgA 
producing cells account for nearly 90% of plasma cells in the colon; the other 
10% are mostly IgM producing cells (Brandtzaeg & Johansen, 2005).  
• Other lymphoid populations in the intestine: Innate lymphoid cells (ILCs) are a 
recently described population, and they are believed to regulate intestinal 
immunity, inflammation and GALT development. Invariant T cells are a 
population that expresses invariant forms of TCR and they include mucosal 
associated invariant T cells (MAIT cells) and invariant natural killer cells 
(iNKTs cells). MAIT cells eventually produce cytokines and exert cytotoxic 
activity, and are selectively activated by infected cells. They constitute a small 
population throughout the intestine (Le Bourhis et al, 2013). Intestinal iNKTs 
produce large amounts of IL-4 and IFN-γ, they are activated via TCR 
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recognition of conserved bacterial glycolipids presented by MHC-I like 
molecule CD1; they are more numerous in the small intestine than in the colon 
(Zeissig & Blumberg, 2013).  
 
1.1.2.2 Innate immune cells distribution in the intestine 
• Intestinal macrophages: They are the most abundant population of leukocytes in 
the lamina propria, and are found relatively close to the epithelial surface. They 
produce large amounts of IL-10, and respond to this cytokine in order to 
maintain local homeostasis. In fact, this seems to be a property exclusive of 
intestinal macrophages as, unlike other tissue macrophages, those in the mucosa 
are derived by continuous replenishment from blood monocytes that are 
differentiated depending of the local mucosal environment (Bain & Mowat, 
2014). It has been suggested that absolute number and relative frequency of 
macrophages is higher in the colon than the small intestine. 
• Intestinal conventional dendritic cells (cDCs): Different subset of dendritic cells 
have been identified in the mouse lamina propria, with expression of invariant 
markers like CD11c+, MHCII+ and F4/80-; the combination of CD11b, CD103 
and regulatory transcription factors define separated subpopulations. While 
CD103+ CD11b+ conform the majority of mouse DCs in the small intestine, 
CD103+ CD11b- are the major subset in the colon. (Denning et al, 2011; 
Watchmaker et al, 2014) .   
• Plasmacytoid dendritic cells (pDCs):  They are present in the intestinal mucosa 
in a lower number than conventional DCs and are found only in the small 
intestine in mice and primates. However, pDCs can migrate to the colonic 
mucosa in response to inflammation. They have been associated with tolerance 
induction and demonstrated protective role in small intestinal inflammation 
models (Mizuno et al, 2012). 
• Eosinophils: In mice, eosinophil number is higher in the duodenum; it has been 
reported that eosinophils are important for maintaining the number of IgA-
producing plasma cells, DCs and Tregs in the small intestine lamina propria 
(Chu et al, 2014). 
• Mast cells: They are found mostly in the lamina propria and submucosa, and 
they produce mediators that regulate epithelial barrier integrity, peristaltic 
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Figure 1. Anatomy of the intestinal 
mucosa and immune population. 
The colon has no villi and mucosa 
consist mainly on crypts with only 
short regions of flat surface 
epithelium. Globet cells, which 
produce a layer of protective mucus, 
are numerous while Paneth cell are 
scarce compared to the small intestine. 
Intestinal epithelial cells (IECs) are 
produced from stem cells near the 
bottom of the crypts. Stem cells give 
rise also to globet cells and Paneth 
cells, which produce antimicrobial 
peptides (AMPs). The majority of 
intestinal immune cells are found at 
the lamina propria whereas 
Intraepithelial lymphocytes (IELs) are 
found lying between epithelial cells. 
The main function of the surface 
epithelium is to reabsorb water from 
faeces and to act as a barrier to 
commensal microbiota. DC, dendritic 
cell; SlgA, secretory immunoglobulin 
A. Modified from (Mowat & Agace, 
2014). 
movements, permeability and vascularization. They can also detect 
microorganisms and, at the colon level, pro-inflammatory mast cells seems to be 
more abundant (Miller & Pemberton, 2002). 
 
 
 
1.1.3 Intestinal inflammatory disease 
IBDs occur at the distal small (Crohn´s disease) and colon (Ulcerative colitis). 
They are originated by an aberrant response to commensal bacteria. The incidence of 
IBDs in western populations is nearly 0.3%. There are numerous animal models for 
intestinal inflammation; interestingly, they do not develop pathology when the animals 
are under germ free conditions (Strober et al, 2002). The murine models have been 
useful to identify the network of principal cytokines with a role in each disease, and are 
an important tool for research.  
Classically, Crohn´s disease has been associated to an inflammatory response 
driven by Th1 and Th17 T cell population, with increased production of IFN-γ. In 
contrast, Ulcerative colitis is apparently due to a Th2 response with increased 
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production of IL-5; however, IL-4 production (Th2 signature) was not increased 
suggesting that UC is rather a Th2-like disease. IL-12 was initially identified as the 
master cytokine driving the Th1 response in CD. In fact, patients with CD exhibited 
increased levels of IL-12 in the lamina propria (Liu et al, 2001). In contrast, TGF-β and 
IL-6 are the major inducer of Th17 cells that produce IL-17 and IL-22, while IL-23 
(produced by macrophages and DCs) interact with differentiated Th17 cells and 
promote their stabilization and expansion. In fact, it has been reported that 
differentiation of Th17 cells that do not receive IL-23 lead to IL-10 production 
(McGeachy et al, 2007). Studies of CD in humans are in agreement with the findings in 
the murine model, which suggest that Th1 response is quantitatively greater than Th17 
(Becker et al, 2006), and beside the fact that both subpopulations may contribute to the 
inflammatory response, the IL-22 cytokine produced by Th17 cells has been suggested 
to play a regulatory effect (Zenewicz et al, 2008). 
In the same direction, studies of experimental UC demonstrated that IL-13 was 
increased, but not IL-4 and that this production came from NKT cells rather than from 
conventional Th2 population (Fuss et al, 2004). In cell transfer colitis as in chemical 
colitis induced by TNBS or dextran sodium sulfate (DSS), it was seen that IL-17 
response was accompanied by an IFN-ɣ response at the earlier onset of the disease. 
Conversely, oxazolone colitis shows the presence of cells producing IL-4 but not IFN-γ, 
increased amounts of TGF-β are also detected. Eventually, the inflammation was 
prolonged but driven by IL-13 secreted by CD4-NKT cells (Fuss & Strober, 2008). 
Then, it has been accepted that inflammatory response in UC is, greatly in part, 
generated by NKTs cytotoxicity which are activated by certain glycolipids that are 
presented by the MHC class I-like CD1; these ligands include self and bacterial lipids. 
This cytotoxic activity leads to ulceration and inflammation, and this is supported by the 
fact that IL-13 which causes epithelial cell apoptosis and loss of the barrier function.  
 
1.1.4 Control of intestinal homeostasis 
In IBD, the innate immune response plays a critical role. Activated DCs and 
macrophages secrete several cytokines that eventually trigger differentiation of T cells 
leading the adaptive immune response. Failed clearance of auto-reactive and over-
reactive cells, in addition to imbalance of Treg/Teff cells, are the responsible of the 
exacerbated inflammation in IBDs. Cytokines IL-1α and IL-β also have up-regulatory 
and pro-inflammatory activities; they are produced by various cell types as 
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macrophages and neutrophils, and act synergistically with TNF-α. Also IL-6, a 
pleiotropic cytokine, contributes with these other cytokines to enhance inflammation. 
Together, they are implicated in blocking apoptosis of T cells and increasing their 
proliferation while promote T effector cell differentiation (Figure 2). 
 
 
 
DCs are thought to be central to mount either a tolerogenic or an immunogenic 
response. It has been suggested that conditioning of DC by epithelial cell derived 
products may be important for the maintaining of intestinal homeostasis. This 
conditioning would allow DCs to induce tolerogenic responses, IL-10 production, in the 
absence of infection.  Different cell types in intestinal mucosa produce TGF-β; this may 
regulate negatively DCs function too, by reducing the expression of MHC class II.  In 
fact, there is a constant migration of DCs from the intestinal to the mesenteric lymph 
node (Msln) and other secondary lymphoid organs. This suggests a constant and active 
tolerogenic activity performed by intestinal DCs (Huang et al, 2000). Then, the accepted 
view is that DCs that migrate in the steady-state from the intestine, previously exposed 
to harmless mucosal antigens, are responsible for the maintenance of tolerance through 
interaction with T cells in the lymph node. This tolerance may be achieved by deletion 
or inactivation of autoreactive T cells, the expansion of active Tregs or the acquisition 
of a regulatory phenotype by naïve T cells. 
Figure 2. Cytokines imbalance. Pro-inflammatory cytokines from effector T cells vs regulatory 
cytokines from Tregs. Modified from (Sanchez-Munoz et al, 2008). 
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The CD4+CD25+Foxp3+ T cells can be seen in the colonic lamina propria in 
mice at steady state, which support their constitutive role in the maintenance of 
tolerance and prevention of aberrant responses to harmless antigens. Indeed, in humans, 
these Tregs where found at higher density in IBD patients compared to healthy donors 
(Uhlig et al, 2006).  Studies in T cell transfer model of colitis suggested an important 
role for IL-10 derived from both Treg and non T-cells. The down-regulatory effect of 
IL-10 includes the inhibition of cytokine production and antigen presentation. Another 
modulatory cytokine is TGFβ, which is important in the differentiation and maintenance 
of functional Tregs in periphery.  
 
1.1.5 PSGL1 structure and function 
P-selectin Glyprotein Ligand-1 (PSGL1) is a 220-kDa disulfide-linked 
homodimeric sialomucin, usually located on the tip of microvilli. It is a transmembrane 
glycoprotein, with an extracellular domain rich in threonine, proline and serine repeats; 
that bears sites for potential O-glycosylation (Figure 2). The aminoacid sequence of the 
human and murine transmembrane and cytoplasmic domains is highly conserved. By 
contrast, the PSGL-1 ectodomain is poorly conserved. PSGL-1 binds the three known 
selectins; lymphocyte selectin (LSel), endothelial selectin (Esel) and platelet selectin 
(Psel) (Ley & Kansas, 2004). Different post-translational modifications of PSGL-1 are 
required for selectin binding, such as sulfation, O- and N- glycosylation, fucosylation, 
sialylation (Figure 3). In fact, avoiding the catalytic effect of one or more of the 
involved glycosyltransferases leads to defects in the leukocyte rolling during the 
extravasation process (Lowe, 2003). 
 
 
 
At inflammatory situations, Esel and Psel, at endothelium, bind to PSGL-1 
initiating the tethering and rolling of leukocytes on the endothelial cells. This represents 
Figure 3. PSGL-1 schematic structure. O-glycosylation sites and their modifications condition the 
binding to PSGL-1 ligands.  
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the first step of the leukocyte extravasation cascade. These selectins can bind with 
different affinities to their counter receptors. This sum with the different expression 
pattern and the signal pathways activated in each case are responsible of the different 
rolling and attachment characteristics of leukocytes to selectins under physiological 
conditions (Sreeramkumar et al, 2013). It has been described that both L-selectins and 
P-selectins bind the same or closely overlapping sites near the amino-terminus of the 
PSGL-1 ectodomain, however the E-selecting biding site has not been mapped yet 
(Goetz et al, 1997).   
PSGL-1 is constitutively expressed in mature leukocytes. Depletion of PSGL-1 
by gene targeting reduces the number of leukocytes interacting with endothelium. 
Although PSGL-1 binds all the selectins, the PSGL-1-/-  mice do not present a severe 
phenotype as the triple selectin knockout Selp-/- /Sele-/- /Sell-/-  mice, confirming that 
other selectin ligands are important (Robinson et al, 1999). 
 
1.1.6 PSGL-1 signaling 
Upon interaction of the PSGL-1 ectodomain with its ligand, the cytoplasmic tail 
associates and induces phosphorylation of tyrosine kinase Syk through the ERM family 
proteins in an ITAM-dependent manner. This intracellular signaling drives the 
activation of the transcription factor c-Fos (Urzainqui et al, 2002). Importantly, it has 
been demonstrated that PSGL-1 plays a role in the induction of peripheral tolerance by 
activating a tolerogenic program in DCs (Urzainqui et al, 2007b).  
DCs play a key role in the induction and regulation of immune response. Upon 
infection/inflammation, DCs activate naïve T cells but in steady-state DCs remain 
immature and interact with T lymphocytes inducing anergy and acting as negative 
regulators. Specifically, engagement of PSGL-1 by P-selectin on immature DCs induces 
the expression of c-Fos, IDO, IL-10 and TGF-β genes; these DCs exert a tolerogenic 
effect in naïve T cells inducing differentiation into CD4+ CD25+FOXP3+ Tregs.  In fact, 
PSGL-1-/- mice showed a lower percentage of natural Tregs in the thymus. Strategies 
aimed at interfering with T-cell accumulation and/or function in the gut have been 
employed with success in patients with IBDs (Monteleone & Caprioli, 2010). As Treg 
populations are key regulators in the homeostasis of intestinal immune system, PSGL-1 
may exert a homeostatic role in the gut-associated lymphoid tissue. 
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1.2 HDAC6: Role at the exocytosis of lytic granules in CD8 T cells  
 
Adaptive immunity involves the differentiation of T cells to effector cells that 
are able to produce and use different secreted soluble factors and membrane-bound 
molecules for highly specific intercellular communication. Development of cytotoxic T 
lymphocytes (CTLs) from activated CD8+ T cells is a key step of the antiviral immune 
response. CTLs can secrete cytokines but also specifically kill infected cells in the 
periphery. This targeted cell killing constitutes a form of communication by which cells 
presenting the appropriate complexes of peptide and major histocompatibility complex 
are “instructed” to die (Huse et al, 2008) 
 
1.2.1 CD8 cytotoxic response 
Cytotoxic cells avoid activation or killing the wrong cell thanks to the specificity 
conferred to the process by the immunological synapse formed between the CTL and 
the antigen presenting cell (APC); i.e.: the target cell. The immune synapse functions as 
a conduit for the transfer of information between the T cell and the APC, and some of 
this information is mediated by cell surface proteins (Bromley et al, 2001). CTL 
maturation involves active synthesis and storage of cytotoxic mediators such as perforin 
and granzymes into the lytic granules, which are derived from lysosomes (Williams & 
Bevan, 2007). 
 
1.2.2 Cytolytic synapse and MTOC translocation 
Cytolytic activity is mediated by the vectorial release of the lytic granule content 
toward the target cell through the so-called cytolytic synapse, which is organized into a 
central secretory domain surrounded by a ring of adhesion molecules, analogous to the 
central supra-molecular cluster (cSMAC) found at the IS between CD4+ T cells and 
APCs. Within minutes of TCR stimulation, MTOC polarizes just beneath the IS (Geiger 
et al, 1982). Newly polymerized microtubules radiate with a defined polarity from the 
MTOC, with “minus” end directed inward and “plus” ends directed outward. Indeed, 
the MTOC is associated with the Golgi apparatus (Kupfer et al, 1983) and its 
reorientation aligns the IS with organelles involved in protein secretion.  
The cytolytic synapse acts as a focal point for the localized exocytosis of lytic 
granules. The movement of the lytic granules occurs immediately after TCR 
stimulation. Granules that are rapidly recruited to the centrosome or microtubule 
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organizing center (MTOC), are subsequently delivered from the IS-polarized MTOC to 
an F-actin depleted zone of the plasma membrane within the central secretory domain 
(Stinchcombe & Griffiths, 2007).   
The immune synapse formation involves an initial burst of actin polymerization at the 
contact site between the T cell and the APC, which then needs to be depleted from F-
actin to facilitate the delivery of the lytic granules, and the subsequent activation of 
integrin-mediated adhesion. This process is dependent on TCR signaling, early 
signaling effector molecules such as Zap70, Lck and Fyn, adaptors such as LAT (Linker 
for activation of T cell), SLP-76, and Vav are also required (Ardouin et al, 2003; Kuhne 
et al, 2003; Martin-Cofreces et al, 2006).  
There are other regulators that have been linked to MTOC polarization. Hence, formin-
like 1(FMNL1) and mammalian diaphanous 1 (mDia1) are involved in the stabilization 
of microtubules at the cell membrane (Andres-Delgado et al, 2013). Another issue 
concerns the functions of the Rho family GTPases. Thus, FMNL1 and Dia1 are directly 
regulated by Rho and Rac and Cdc42 is also required for MTOC polarization (Faix & 
Grosse, 2006). The precise concert of all these molecules working together for the 
polarization response remains unclear. 
 
1.2.3 Polarization of lytic granules  
Two main movements are involved in cytolytic granule polarization: initial 
granule recruitment to the MTOC and MTOC polarization toward the plasma 
membrane. In this regard, polarization of the MTOC to the CTL contact interface is an 
essential step for effective cytolytic activity (Stinchcombe et al, 2006). These 
movements require the activation of the same set of signaling proteins, induced by TCR 
engagement, but can be uncoupled. The adaptor molecule LAT is recruited to 
signalosomes and subsequently phospholipase Cγ 1 (PLCγ1) is activated, which cleaves 
PIP2 and produces diacylglycerol (DAG) and IP3; the latter initiates mobilization of 
intracellular Ca2+ (Huse et al, 2006; Stinchcombe & Griffiths, 2007). In fact, MTOC 
polarization requires the tethering of microtubules to remodeled actin cytoskeleton, 
while granules concentration around the MTOC can occur without cytoskeleton 
remodeling. 
Lytic granules can take either a “short” or “long” path to the cytolytic synapse 
resulting in distinct patterns of polarization.  Both paths use the same intracellular 
events but with a different spatial and temporal arrangements, and these are regulated by 
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the kinetics of downstream Ca2+ mediated signaling. Rapid signaling causes granule 
concentration near the MTOC and subsequent delivery by the MTOC translocation 
directly to the secretory domain (the shortest path). In contrast, a weak signaling leads 
to late recruitment of granules that move along microtubules to the periphery of the 
synapse and then relocate tangentially to fuse at the outer edge of the secretory domain 
(a longer path) (Beal et al, 2009; Poenie et al, 2004). The shortest pathway is associated 
with faster granule release and more efficient killing than the long pathway (Figure 4). 
Thus, the kinetics of early signaling regulates the quality of the T cell cytolytic response 
but the mechanism that control which delivery pathway the lytic granules takes to the 
synapse remains unknown. It has also been recently described that CTLs may kill their 
target without centrosomal localization at the IS and that there is a rapid and effective 
movement of lytic granules that precedes the centrosomal polarization in CTLs 
(Bertrand et al, 2013). Therefore, part of the control of cytotoxicity may rely on MTOC 
translocation, but the movement of the granules themselves may constitute the actual 
mechanism used by CTLs to control their lytic activity. 
 
 
 
 
The release of lytic granules into the synaptic cleft allows the selective killing by 
limiting the exposure of surrounding cells to the lytic granule content. CTLs do not 
exhaust their lytic granules content during the contact with a unique target cell. The 
lytic granules remain often concentrated around the MTOC even though the latter 
Figure 4. Polarization of lytic machinery and path to target cell. In CTLs in the absence of a target 
cell (I), the MTOC (green) has a perinuclear location, and the lytic granules (red and blue) are 
distributed all along the microtubules. Upon target cell contact, and TCR recognition, MTOC and 
Golgi apparatus relocate to the IS. Lytic granules that cluster surrounding MTOC (II) are delivered 
directly –short path- (III) to the secretory domain where they can fuse with membrane and release their 
content to target cell (IV). Lytic granules can move along microtubules (II and III) to the periphery of 
the synapse looping through pSMAC (IV) -long path. Based on (Beal et al, 2009). 
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moves away from the contact area, which allows the CTLs to rapidly move the lytic 
granules toward the next target cell (Stinchcombe & Griffiths, 2007).  
Trafficking of vesicular compartments is mediated by distinct families of 
proteins, such as the SNARE proteins (soluble N-ethylmaleimide-sensitive factor 
accessory protein receptors). They conform an important family of helical 
transmembrane proteins that interact in trans, between members of the family found in 
either target membranes (t-SNARE proteins) or vesicles (v-SNARE proteins). Upon 
both kind of proteins form hetero-oligomers through their coiled-coil domain, the 
vesicle fusion with the membrane is observed and secretion allowed (Jahn et al, 2003; 
Parlati et al, 2002). SNARE interactions are regulated by different groups of proteins 
that confer specificity to the trafficking process. These have been extensively studied in 
neurons; Munc13-1 facilitates the interaction of v-SNARE and t-SNARE and 
Synaptotagmin regulates the neuronal vesicle fusion that couples calcium influx to the 
formation of the SNARE complex (Chapman, 2008). Indeed, the Rab family of small 
GTPases, important for the specification of intracellular traffic, associate with vesicular 
structures through their carboxyl terminus and recruit various effector molecules and 
tethering complexes that confer the identity of the vesicle (Zerial & McBride, 2001). 
 
1.2.4 Associated pathologies 
Interestingly, some studies have reported genetic disorders that combine 
immunodeficiency with albinism. Both CTLs and melanocytes secrete lysosome-
derived vesicles (lytic granules and melanosomes respectively).  
 
• Griscelli syndrome relates defective CTL function and albinism due a mutation 
at the Rab27a gene. It is reported that loss of the protein allows the polarization 
of lytic granules as a response to TCR stimulation, but granules fail to dock at 
the plasma membrane (Menasche et al, 2000). 
•  In Hermansky-Pudlak syndrome type 2, the albinism is produced by a mutation 
in the adaptor protein 3 (AP-3) gene. AP-3 promotes the sorting of lysosome 
cargo. CTLs deficient for AP-3 have enlarged lytic granules that do not polarize 
to the immune synapse (Clark et al, 2003).  
• Chediak-Higashi syndrome combines albinism and a lymphoproliferative 
alteration. CTLs show defective exocytosis due to mutation in the gene coding 
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for LYST (lysosomal trafficking regulator) and they are characterized by 
enlarged lytic granules (Sepulveda et al, 2015). 
 
1.2.5 Tubulin motors, dynein and kinesin 
The tubulin motors mediate the redistribution of lytic granules towards the target 
cell with exquisite specificity. It has been shown that dynein promotes the transport of 
lytic granules along microtubules toward the MTOC in a “minus end” direction 
(Mentlik et al, 2010). This convergence of lytic granules with MTOC occurs long 
before its polarization toward immune synapse, and is independent of commitment to 
cytotoxicity. It was demonstrated that lytic granule convergence occurs in cells treated 
with actin cytoskeleton disrupting drugs such as cytochalasin D or latrunculin A. Given 
that microtubules are oriented with their plus ends toward the cell membrane, a 
negatively directed motor anchored to the IS could pull the MTOC toward it, as a 
mechanism to polarize the ensemble to the IS. The fact that the convergence of lytic 
granules occurs independently of cytotoxicity, prevents their secretion until gradual 
MTOC polarization brings them into proximity to the immune synapse. 
Eventually, close to the immune synapse, the lytic granules acquire effector 
exocytic molecules like Rab27a and Munc13-4 that enable the functional maturation of 
lytic granules (Menager et al, 2007). An additional downstream step that has been 
demonstrated, Figure 5, includes the recruitment of Slp3 by the granule-associated 
Rab27a and the interaction with the C-terminal of the kinesin 1 light chain (KLC1). The 
complex formed by Slp3 and Rab27a and kinesin-1 drives the terminal transport of lytic 
granules towards the plasma membrane, along the “plus end” direction of the 
microtubules inserted into the reorganized F-actin network, for directed degranulation at 
the secretory domain (Kurowska et al, 2012).  
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1.2.6 HDAC6 structure 
Histone deacetylase 6 (HDAC6) is an ubiquitous cytosolic protein that binds to 
and deacetylates α-tubulin at lysine 40 in vivo and in vitro (Hubbert et al, 2002; 
Valenzuela-Fernandez et al, 2008). The lysine deacetylation is a dynamic and reversible 
process regulated by the action of antagonistic enzymes, histone acetyltransferases 
(HATs) and histone deacetylases (HDACs). HDAC6 is a class IIb HDAC that contains 
two catalytic domains for deacetylation and a C-terminal zinc finger domain (BUZ) that 
binds free ubiquitin as well as mono- and poly-ubiquitinated proteins with high affinity 
(Li et al, 2013). Also, HDAC6 harbors: i) a SE motif that confers its cytoplasmic 
location; ii) a ¨nuclear export signal¨ and a ¨nuclear localization signal¨ that export to 
cytoplasm or retain in the nucleus the entire or part of the protein,  and a iii) dynein 
binding site between both catalytic domains, Figure 6, (Kawaguchi et al, 2003).  
Figure 5. Terminal transport of lytic granules at IS.  Two successive steps have been described in 
lytic granule transport at IS formation. A first minus end directed transport dynein-dependent recruits 
the granules to the MTOC and allows their transport associated with the MTOC translocation bringing 
them near to the IS.  Then a second plus end directed transport kinesin-dependent enables the terminal 
polarization of cytotoxic granules and their fusion with membrane and release their content. Modified 
from (Kurowska et al, 2012) 
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Microtubules are polarized filaments composed of α-tubulin and β-tubulin 
heterodimers, which are in constant polymerization and catastrophe (depolymerization) 
events. In this regard, acetylated microtubules have been largely considered as stable 
microtubules, with long lifetime. HDAC6 also modulates other cytoplasmic substrates, 
e.g. cortactin, hsp90 or β-catenin.  
 
1.2.7 HDAC6 physiological functions  
Through specific deacetylation of its targets, HDAC6 may control different aspects 
of cell biology, such as: 
• Cell migration. HDAC6 ablation leads to hyperacetylation of cortactin at its 
repeat region. This prevents cortactin translocation to the cell periphery, where 
it may associate with F-actin, impairing the actin-depend cell motility (Zhang et 
al, 2007).  
• T-regulatory functions. HDAC6 inhibition and/or depletion promotes 
suppressive functions of Foxp3+ through the hyperacetylation of HSP90 and 
disruption of its key chaperone functions. In fact, HDAC6 Tregs express more 
Foxp3, CTLA-4 and IL10 (de Zoeten et al, 2011). 
• Transcription and signaling. HDAC6 knockout decreases proliferation, colony 
formation and invasion in tumor and xenograft models. CD133 links HDAC6 
and forms a complex that negatively regulates the endosome trafficking, which 
allows the deacetylation of β-catenin thereby stabilizing it and preventing its 
degradation (Mak et al, 2012). 
•  CD4+ T cell activation. HDAC6 mediated α-tubulin deacetylation plays a role 
in the organization of the immune synapse. In T cells, overexpression of 
Figure 6. Functional domains of HDAC6. HDAC6 contains two catalytic domains (DD1 and 
DD2), a nuclear export signal (INES) prevents the accumulation in the nucleus and the Ser-Glu tetra-
peptide (SE14) which ensures stable anchorage in the cytoplasm.  HDAC6 also contains a high 
affinity ubiquitin-biding zinc finger domain (BUZ). Modified from (Li et al, 2013).  
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HDAC6 disorganizes CD3 and LFA-1 at the immune synapse and also impairs 
MTOC translocation and IL2 production upon activation of T cells. These 
effects are reverted by TSA treatment (Serrador et al, 2004). 
• Regulation of the aggresome formation. HDAC6 is selective involved in 
polyubiquitin-enriched aggresome formation, facilitating the loading of 
polyubiquitinated misfolded cargo to the dynein motors for their transport to the 
aggresome (Kawaguchi et al, 2003). Aggresomes are uniquely located close to 
the MTOC; disruption of microtubule network or dynein motor function 
prevents the aggresome formation (Johnston et al, 2002). Misfolded proteins are 
the result of genetic mutations, inappropriate protein assembly, aberrant 
modifications and environmental stress. These proteins should frequently be 
poly-ubiquitinated to be degraded at the proteasome; if they aggregate, their 
degradation by the proteasome fails, promoting cell toxicity (Kopito, 2000).  
• Chemotaxis. HDAC6 is required for T cell migration. HDAC6 is highly 
concentrated in regions with protrusive activity in migrating lymphocytes. Its 
over-expression increases migration and its knockdown diminish their 
chemotactic capability. Interestingly, the over-expression of a non-functional 
mutant of HDAC6 resembles the increased migration phenotype observed in 
cells over-expressing the wild-type form of the protein and its enzymatic 
inhibition does not decrease the migration as the knockdown does. Therefore, 
HDAC6 plays a role in the chemotaxis of lymphocytes as a scaffold protein 
independently of its enzymatic activity   (Cabrero et al, 2006).  
1.2.8 HDAC6 deletion vs inhibition at the immune response 
Mice lacking HDAC6 are viable and fertile and show hyperacetylated tubulin in 
most tissues; the lymphoid development is normal and seemed to have a moderated 
impact in the immune response (Gao et al, 2007; Zhang et al, 2008). 
Results obtained with the use of inhibitors that show different selectivity for the 
diverse HDACs, identified to date, do not clarify the precise role of a protein like 
HDAC6, that can exert different functions beside the enzymatic context, e.g. the 
scaffold function in the chemotactic capacity of lymphocytes (Cabrero et al, 2006; 
Valenzuela-Fernandez et al, 2008). In fact, even though multiple efforts in developing 
specific inhibitors, they have failed in achieving relative good specificities and their use 
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may lead to uncontrolled, off-target effects due to the number of deacetylase members 
with different degrees of homology to the desired HDAC (Table 1). By inhibition of 
deacetylase activity of HDACs it has been reported that some inhibitors abrogate the 
induction of T cell activation in CD8+ T cells (Mosley et al, 2006; Tsuji et al, 2015). 
These authors propose that hyperacetylation of HSP90 enhanced its binding to 
lymphocyte-specific tyrosine kinase (LCK) and disrupted its phosphorylation stage 
leading to TCR signaling pathway impairment. This suggests that this function may 
depend on enzymatic activity of HDAC6. However, in CD4+ T cells Trichostatin A 
(TSA), a pan-inhibitor of HDACs which includes HDAC6, does not abrogate T cell 
receptor signaling but prevents signaling complexes formed by phosphorylated CD3ζ 
and ZAP70 from interact to tubulin (Serrador et al, 2004). 
 
 
 
 
Tubacin 
Tubacin is a highly potent and selective, reversible, cell-permeable HDAC6 inhibitor 
with an IC50 of 4 nM, approximately 350-fold selectivity over HDAC1. 
Tubastatin A 
Tubastatin A is a potent and selective HDAC6 inhibitor with IC50 of 15 nM. It is 
selective against all the other isozymes (1000-fold) except HDAC8 (57-fold). 
Rocilinostat 
(ACY1215) 
Rocilinostat (ACY-1215) is a selective HDAC6 inhibitor with IC50 of 5 nM. It is >10-fold 
more selective for HDAC6 than HDAC1/2/3 (class I HDACs) with slight activity against 
HDAC8, minimal activity against HDAC4/5/7/9/11, Sirtuin1, and Sirtuin2. Phase 2. 
CAY10603 
CAY10603 is a potent and selective HDAC6 inhibitor with IC50 of 2 pM, >200-fold 
selectivity over other HDACs. 
Nexturastat A 
Nexturastat A is a potent and selective HDAC6 inhibitor with IC50 of 5 nM, >190-fold 
selectivity over other HDACs. 
HPOB 
HPOB is a potent, selective HDAC6 inhibitor with IC50 of 56 nM, >30-fold selectivity 
over other HDACs. 
 
Table1. List of specific HDAC6 inhibitors 
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2. OBJECTIVES 
 
2.1    Study of the regulatory role of PSGL-1 in Ulcerative colitis.  
 
2.2  Determination of the role of HDAC6 in the exocytosis of lytic granules in CD8 
T cells. 
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3. MATERIAL AND METHODS 
 
3.1 Reagents and monoclonal antibodies. 
 
3.1.1 PSGL-1: regulatory role at Ulcerative colitis 
The following conjugated antibodies were obtained from BD Pharmingen (San 
Jose, CA, USA): anti-CD11c-PECy7, F4/80-biotin, Ia-Ie-MHCII -FITC, CD4-PE, CD8-
APC, CD25-biotin, B220-FITC, Gr1-APC, DX5α-biotin, CD3-FITC, IL-12-PE, IL-10-
PE, IFN-γ-FITC, IL-4-APC, IL-17-PE and streptavidin-PerCP. DSS was from MP 
Biomedicals, LLC (Illkirch, France). Collagenase IA, dispase, DNAse I and the TRI® 
Reagent were from Sigma-Aldrich (St. Louis, Mo, USA). The mouse Th1/Th2 10plex 
Kit was from Bender Medsystems GmbH (Vienna, Austria). Tissue proteins were 
extracted with T-PER® Tissue Protein Extraction buffer from Thermo Scientific 
(Rockford, IL, USA), and quantified with the BCA™ Protein Assay Kit (Pierce, 
Rockford, IL, USA). 
 
3.1.2 HDAC6: Role at the exocytosis of lytic granules in CD8 T cells  
The antibodies used in this study were from BD pharmingen (p150-glued, p50-
dynamitin), BD (CD4-, CD8-, Ia-Ie-MHCII- and CD44-FITC (fluorescein 
isothiocyanate); CD11b-, CD11c- CD8- and CD3-PE (phycoerythrin); Gr1-, CD3-, 
IFN-γ- and CD8-APC (allophycocyanin); biotinylated CD80 and  stimulating CD3 
(clone 2C11) and CD28 antibodies), Millipore (KLC), Sigma (anti-α-tubulin clone 
DM1A, vimentin), Cell Signaling (phospho-Erk 1/2, phospho-PLCγ1 (Y783), PLCγ1), 
Abcam (Cathepsin D) eBioscience (Perforin1 (clone JAW246), lamp1(CD107a)-alexa 
647, IFN-γ ELISA), Abnova Bio (Perforin1, rabbit source) and Assay Biotech 
(HDAC6; reference CO226). Dextramer for H-2KbOVA detection was from Immudex. 
Reagents from Invitrogen (CMAC (7-amino-4-chloromethylcoumarin), Cell violet and 
Lysotracker Red probes), Electron Microscopy Sciences (EMS; 16 % 
paraformaldehyde, electron microscopy grade) were also used. OVA-derived peptides 
were chemically synthesized (Lifetein) and probed against LPS (lipopolysaccharide 
ENDOlysa from Hyglos).  
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3.1 Mice.  
 
3.2.1      PSGL-1: regulatory role at Ulcerative colitis 
C57Bl/6 PSGL-1-/- mice were kindly provided by Dr. M.K. Wild and Dr. D. 
Vestweber (Max Planck Institute for Molecular Biomedicine, Münster, Germany). 
C57Bl/6 WT mice were obtained from the Jackson Laboratory.  
3.1.2 HDAC6: Role at the exocytosis of lytic granules in CD8 T cells  
HDAC6 knockout mice were kindly donated by Tso Pang Yao lab´s (Gao et al, 
2007) and was intercrossed in a C57BL/6 background to generate wild-type (WT; 
hdac6+/+) and knockout (KO; hdac6-/-) HDAC6 littermates. TCR (Vα2, Vβ5) transgenic 
mice (OT-I) were crossed to HDAC6 heterozygous mice in order to generate WT and 
hdac6-/- OT-I transgenic mice.  rag1-/- mice were used for adoptive transfer experiments.  
 
3.3 Methods 
 
3.3.1 PSGL-1: regulatory role at Ulcerative colitis 
 
3.3.1.1 Cell preparation from tissues and analysis  
To prepare cell suspensions from LP, colons were extracted, washed with PBS, 
cut into 1mm pieces and incubated in RPMI medium supplemented with 4% fetal calf 
serum and 1 mg/ml collagenase IA, 1mg/ml dispase and 40 µg/ml DNAse I in a shaking 
bath at 37ºC for 1h. Then, cells were washed, suspended in PBS containing 1% 
BSA,0.5M EDTA, and labeled for cell cytometry analysis. To measure cytokines, 
colons and mLN were frozen in liquid nitrogen, powdered and suspended in protein 
extraction lysis buffer. Protein content was quantified with the BCA™ kit and cytokine 
levels were determined with the cytokine Mouse 10plex Kit, following manufacturer´s 
instructions. 
3.3.1.2 Induction of colitis and disease evaluation.  
Colitis was induced by daily administration of 4% or 1% DSS (molecular weight 
30,000 to 40,000) dissolved in drinking water. The clinical parameters used to score the 
disease (Disease Activity Index or DAI) were weight loss, loose stools/diarrhea and 
presence of occult/gross bleeding (Cooper et al, 1993). Animals were weighed before 
starting the treatment (initial weight) and every day until the end of the treatment. 
Animals were also checked daily for stool consistency and for the presence of blood in 
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the stools. At the end of treatment, colons were processed for histological analysis, to 
check for the presence of infiltrate in the LP, or disaggregated and processed to study 
the immune cells present in the colonic LP infiltrate.  
 
3.3.2 HDAC6: Role at the exocytosis of lytic granules in CD8 T cells  
 
3.3.2.1 Quantitative real-time PCR. Total RNA was isolated using an RNeasy 
kit (Qiagen). RNA samples were reverse-transcribed using random primers and 
SuperScript II reverse transcriptase and qPCR was done by nonspecific product 
detection (SYBR Green; Applied Biosystems) of cDNA. Primer sequences are: GzmB, 
forward, 5′-TCACAAGGACCAGCTCTGTCCT-3′, reverse, 5′-
GTTGGGTTGTCACAGCATGG-3′; Eomes, forward, 5′-
CCCCTATGGCTCAAATTCC-3´, reverse, 5´-CCAGAACCACTTCCACGAA-3´; 
Perforin, forward, 5′- GAGAAGACCTATCAGGACCA -3′, reverse, 5′- 
AGCCTGTGGTAAGCATG -3′; Cathepsin D, forward, 5′- 
CTGAGTGGCTTCATGGGAAT -3′, reverse, 5′- CCTGACAGTGGAGAAGGAGC -
3′. 
3.3.2.2 In vitro degranulation assay. Cell degranulation was measured by 
monitoring the expression of the lysosomal marker CD107a, EL4 pulsed with 1µM of 
SIINFEKL were used to stimulate CD8+ OTI cells in the presence of Monensin 5mM 
and anti-CD107a Alexa 647 antibody during 3h at 37 ºC in 5%CO2. Thereafter, cells 
were stained with anti-CD8 PE and anti-CD44 FITC (BD Biosciences), and analyzed by 
flow cytometry. Data were analyzed with FlowJo Version 7.6.5 software (TreeStar). 
 
3.3.2.3 Cell conjugate formation and confocal analysis. EL-4 cell line was 
loaded with the CMAC cell tracker (10 μM) and pulsed with the specific OVA agonist 
peptide SIINFEKL for 2 h at 37 ºC. Target cells (1 × 106 cells) were mixed with the 
CD8+ CTLs (1:1) and plated onto Poly-L-Lys-coated slides (50 μg/ml). Cells were 
allowed to settle for the times indicated at 37 °C, fixed with 4% paraformaldehyde in 
PHEM (60 mM PIPES, 25 mM Hepes, 5 mM EGTA, 2 mM MgCl2), and permeabilized 
for 2 min at room temperature with 0.2% Triton X-100 in immunofluorescence solution 
(PHEM containing 3% BSA, 100 μg/ml γ-globulin and 0.2% azide) when needed. 
Preparations were blocked for 30 min with immunofluorescence solution and stained 
with the indicated primary and Alexa Fluor 488, 568 or 647-labeled secondary 
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antibodies, except for the fluorochrome-conjugated primary antibodies (FITC-anti-α-
tubulin, 647-CD3ε, 647-lamp1(CD107a). Cells were mounted on Prolong Gold 
(Invitrogen) and analyzed under a Leica SP5 confocal microscope (Leica) mounted on 
an inverted DMI6000 microscope fitted with a HCX PL APO 63x/1.40-0.6 oil 
objective. Co-localization analysis was performed with Imaris Software; the 
fluorescence corresponding to the CTL was analyzed, excluding volumes corresponding 
to the target cell. Briefly, an image mask was generated from the CMAC channel (target 
cell) and substracted from the Prf1 and CD107a (Lamp1) channels prior to the 
calculation of co-localization volumes and the Mander’s coefficient (absolute intensity 
of fluorescence values).  
 
3.3.2.4 Total internal reflection fluorescence (TIRF) video microscopy. CD8+ 
CTLs were allowed to settle onto glass bottom dishes (No 1.5 Mattek; Ashland, MA, 
US) coated with anti-CD3 (10 µg/ml) and anti-CD28 (3 µg/ml). Recording was initiated 
upon cell adhesion to the plate, and cells were visualized with a Leica AM TIRF MC M 
system mounted on a Leica DMI 6000B microscope coupled to an Andor-DU8285_VP-
4094 camera fitted with a HCX PL APO 100.0x1.46 OIL objective. Images were 
processed with the accompanying confocal software (LCS; Leica). The laser penetrance 
used was 90 nm (561 nm laser). Time-lapse settings were optimized for each type of 
experiment and are specified throughout the text. Synchronization was performed with 
the accompanying Leica software, while Imaris® software and Image J were used 
respectively for 3D analysis and preprocessing. The study of the mechanical properties 
of the lytic granules was performed instead with a user-customized routine developed in 
Python, using the necessary packages for image analysis and numerical calculations 
(and for the graphical interface). To detect lytic granules we developed a blob-like 
structure detection algorithm working on the intensity image and on its first derivatives; 
detection parameters were kept constant for all the analyzed stacks. Granules detected in 
each frame were tracked along the stack looking at the distances of their centers of 
mass: manual adjustments were allowed too. After tracking, for each of the identified 
granules, the software records their average fluorescent intensity and their surface for 
each time step. Diffusion coefficient for each granule was estimated as the ratio between 
the surface of the smallest polygon including the whole trajectory and the number of 
time steps of the trajectory itself. The software maybe freely downloaded from: 
https://dl.dropboxusercontent.com/u/4050954/VesiclesAnalyser.zip 
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3.3.2.5 Vaccinia virus (VACV) infection and virus titration. Mice were skin 
scarified with the virus (2x106 PFU/mouse), the tail skin area was gently scratched 25 
times with a 28 1/2 G needle. For virus titration, the scarified tails were mechanical 
disaggregated in 1ml of PBS. After 1 freeze-thaw cycles and sonication, serial dilutions 
of the tail homogenates were added to monolayers of CV-1 cells seeded in 24 well 
plates. Cristal violet was used to stain the cells 24 hours later. We observed a detection 
limit of 5 PFU/tail, the number of plaques was multiplied by the reciprocal of sample 
dilution and converted to p.f.u./g. 
 
3.3.2.6 In vitro cytotoxicity assay. EL4 targets were incubated with 1 μM Cell 
Violet and pulsed with 1 μM SIINFEKL or with 0.1 μM Cell Violet and no SIINFEKL, 
washed, and used as targets. These targets were mixed with different dilutions of 
effectors, as indicated, and plated by triplicate in a 96-well U-bottom plate. Following 
incubation for 4 hours at 37°C, Propidium iodide (or PI) was added to exclude dead 
cells and samples were analyzed by flow cytometry. The mean percentage of survival in 
antigen-loaded targets was calculated relative to antigen-negative internal controls in 
each sample. The percentage of specific lysis was calculated using the following 
equation: percentage specific lysis = 100 * (1 - ( % Cell Violet 1µM/ % Cell Violet 
0,1µM). All data were adjusted to the basal specific lysis in absence of effector cells. 
 
3.3.2.7 In vivo cytotoxicity assay. WT and hdac6-/- mice were immunized by 
i.p. injection of bone marrow dendritic cells pulsed with 1µM of SIINFEKL and LPS 
1µg/ml for 1h. After 7 days, CD45.1 splenocytes were used as targets and split into two 
populations labeled with 1 μM Cell Violet and pulsed with 1 μM SIINFEKL or with 0.1 
μM Cell Violet and no SIINFEKL, washed, and used as targets, and injected i.p. into 
recipients. Cells were recovered 16 hours later by peritoneal lavage and in vivo killing 
measured by flow cytometry.  
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4. RESULTS AND DISCUSSION 
 
4.1 PSGL-1: regulatory role at Ulcerative colitis 
 
4.1.1 Distribution and activation state of LP leukocytes 
Commensal bacteria (microbiota) normally exist in a symbiotic relationship with 
the host intestine, but members of the microbiota can opportunistically invade mucosal 
tissues, causing serious problems in immunodeficient individuals. To ensure protection 
of the host against such opportunistic bacterial invasions, the balance between tolerance 
and immunity must be tightly regulated, and this intestinal homeostasis is maintained by 
the immune system (Hooper & Macpherson, 2010; Tlaskalova-Hogenova et al, 2004). 
We analyzed the phenotype of the leukocytes in the colonic LP of PSGL-1 
deficient mice and found a relative increased numbers of granulocytes, CD8+ cells and 
B cells (Figure 1). In contrast, a diminished number of macrophages (F4/80+), DCs 
(lineage negative, CD11c+) and NK cells (DX5α+) was observed in the LP of the KO 
mice. 
 
 
It is very likely that the lower proportion of dendritic cells (CD11c+), 
macrophages (F4/80+) and NKs (DX5α+) at the steady state condition is caused by a 
reduced recruitment of these cells to the LP. By contrast, the percentage of total 
leukocytes (CD45+) including granulocytes (Gr1+) and CD8+ T cells showed relative 
higher proportions. This phenotype suggests two possibilities: that it may occur an 
intrinsic increased proliferation of the resident sub-population in the LP, or that some 
Figure 1. Resident leukocyte subpopulations in the colonic lamina propria (LP) of PSGL-1-/- 
mice. Cell suspensions were obtained from colons of WT and PSGL-1 KO mice, stained with a 
cocktail of antibodies and analyzed by FACS. Percentage of CD45+ cells in the LP infiltrate and 
percentages of granulocytes (Gr1+), B cells (B220+), macrophages (F4/80+), DC (CD11c+), CD4+ T 
cells, CD8+ T cells and NK cells (DX5+) present in the CD45+ cell population. Data are means ± SD 
(n=10 mice). 
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extravasation signal may overcome the defect in their recruitment. In these populations 
PSGL-1 seems to be not crucial for their homing to LP.  
In addition, we could not detect DCs from lamina propria of PSGL-1 knockout 
mice expressing low levels of MHC-II (data not show). Moreover, all PSGL-1-/- 
macrophages expressed the co-stimulatory molecule CD86, whereas only 20% of WT 
macrophages were positive for this molecule (Figure 2).  
 
 
 
 
The higher rate of activated macrophages (CD86+) observed in lamina propria 
suggests the presence of an activation signal even at steady state. Given that these 
knockout mice do not develop spontaneous disease, the contribution of this activated 
population seems to be necessary or at least it is not impairing the homeostasis in gut. 
These data suggest that in the colonic LP of PSGL-1-/- mice most DCs and macrophages 
are in activated state, likely acting as efficient antigen presenting cells. Macrophages are 
inferior to DCs in their ability to prime naïve T cells (Mildner & Jung, 2014); this 
characteristic may be due to their ability to rapidly degrade ingested proteins, which 
impairs their capacity to retain antigens for presentation. 
 
4.1.2 Effect of anti-PSGL-1 antibody on the recruitment of leukocytes to the LP 
In order to characterize the leukocyte subsets that require PSGL-1 for their 
recruitment to the colonic LP, we treated WT mice in vivo with the 4RA-10 anti PSGL-
1 antibody. The in vivo blockade of PSGL-1 in the lamina propria at steady state was 
analyzed 18 hours after the administration of the last dose of the antibody. The binding 
of the 4RA-10 antibody resembles the functional silencing of PSGL-1, when this is 
deleted, blocking interaction with the natural ligands. Anti-PSGL-1 treatment reduced 
Figure 2. Expression of activation markers in myeloid cells from LP. The bar chart shows the 
percentage of F4/80+ cells that express the co-stimulatory molecule CD86 (mean ± SD; n = 5 mice). 
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Figure 3. Effect of PSGL-1 blockade on LP. 
C57BL/6 mice were injected i.v. with the blocking 
anti-PSGL-1 antibody (4RA-10) or rat IgG as 
control.(A) The total number of leukocytes 
population from lamina propria are shown; (B) and 
the expression level of MHC-II in DCs and 
macrophages. (mean ± SD; n = 5 mice). 
the total number of macrophages, DCs and B cells in the colonic LP which is consistent 
with proportions observed in PSGL1-/- mice, whereas other leukocyte subsets remained 
unchanged (Figure 3A). 
 
 
 
 
These data are in accordance with our previous results and other reports 
demonstrating the importance of PSGL-1 in the recruitment of lymphocytes to LP 
(Haddad et al, 2003). In fact, it has been reported the use of immune-blocking of PSGL-
1 antibody to attenuate established murine colitis by reduction of leukocytes recruitment 
(Rijcken et al, 2004). Therefore, since the balance between some subpopulations is 
broken while other maintain their proportions when deleting or blocking PSGL-1, 
suggest that there are some specific populations which are more prone to impair their 
homing when PSGL-1 interaction with its counter ligands does not occur at steady state 
conditions. In our experiments we found that specifically DCs, macrophages and B cells 
impair their homing when PSGL-1 is blocked. 
The treatment with anti-PSGL-1 also resulted in a diminished expression of 
MHC-II by macrophages and DCs (Figure 3B), indicating that 4RA10 acts as an agonist 
of P-selectin and generates an equivalent signal of the interaction with the selectin-
ligand, concurring with our previous results showing that signals through PSGL-1 result 
in induction of a tolerogenic phenotype with low class II expression in DCs. Our results 
suggest that PSGL-1 could be playing a dual role in the recruitment of leukocytes but 
also contributing to the activation state of DCs and macrophages in the lamina propria. 
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4.1.3 Study of environment in colonic LP, balance of Th1, Th2, Th17 and Tregs. 
 We then assessed the profile of cytokine production by resident DCs and 
macrophages in the colonic LP of WT and PSGL-1-/- mice under steady state conditions. 
As shown in Figure 4, most DCs and macrophages from WT mice synthesized IL-10, 
with only a small percentage of cells producing IL-12, IL-4, IL-17 or IFN-γ. In contrast, 
in PSGL-1 deficient mice, the number of IL-10+ DC and macrophage was markedly 
reduced, whereas the proportion of cells  producing IL-12, IL-4 and IL-17 was 
increased, a cytokine profile that may favor the generation of inflammatory phenomena.  
 
 
 
 
Dendritic cells and macrophages have distinct, yet complementary roles in 
maintaining gut homeostasis and immune defense.  Dendritic cells, with their migratory 
capacity, translocate from the lamina propria to the gut-draining mesenteric lymph 
nodes and Peyer´s patches where they present antigens to B cells and naïve T cells and 
polarize them toward effector fates. Macrophages are believed to contribute to the local 
clearance of bacteria, translate alert signals to other immune cells, secrete cytokines and 
re-stimulate T cells to maintain the homeostasis in the lamina propria.  
The cytokine profile and phenotype of PSGL-1-/- LP macrophages and DC 
indicate that they are in an activated state (CD86 and MHC-II expression and enhanced 
synthesis of IL-4, IL-12 and IL-17, with a diminished production of IL-10), a 
Figure 4. Innate cells populations in PSGL-1-/- mice at steady state. Percentage of different 
macrophage (F4/80+) and DC (CD11c+) effector subpopulations resident in the CD45+ infiltrate of 
colonic LP from WT and PSGL-1 KO mice. Cells were analyzed by FACS after intracellular staining 
for IL-4, IL-10, IL-12, IL-17 or IFN-γ. Data are means ± SD (n=6 mice). 
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phenomenon that could be causally associated with the increased numbers of 
granulocytes, B cells and CD8+ T cells. 
 It has been widely described that IL-10 is a potent suppressor of classical 
macrophage activation (Bogdan et al, 1991), and animals deficient in this cytokine show 
spontaneous intestinal inflammation (Kuhn et al, 1993) as well as enhanced synthesis of 
the pro-inflammatory cytokines IL-12 and TNFα (Gazzinelli et al, 1996). Consistently, 
in the LP of PSGL-1-/- mice, the presence of IL-10 producing DCs and macrophages is 
markedly reduced. 
Several studies in IBDs models have shown that most immunoregulatory events 
are controlled by T-cells, and the activation is antigen-dependent, originated from 
intestinal bacteria (Ergin et al, 2008). For this reason, we also studied the characteristics 
of resident T lymphocytes in the colonic LP. As shown in Figure 4B, an enhanced 
number of IFN-γ+ or IL-4+ CD4 T lymphocytes was detected in PSGL-1-/- mice. In 
addition, an increased proportion of IL-4+ CD8+ T cells were observed in these animals 
(Figure 5).  
 
 
 
T cells may accumulate in the lamina propria as a result of multiple mechanisms, 
including enhanced recruitment of cells from the bloodstream, sustained cell cycling 
and diminished susceptibility of cells to undergo apoptosis. Regarding regulatory cells, 
the percentage of T cells with a regulatory phenotype (CD25high Foxp-3+) was 
significantly reduced in the LP of PSGL-1 deficient mice (Figure 6).  
 
Figure 5. T cell population in PSGL-1-/- mice at steady state. Percentage of CD4+ and CD8+ effector 
subpopulations in the CD45+ infiltrate of colonic LP from WT and PSGL-1 KO mice. Cells were 
analyzed by FACS after intracellular staining for IFN-ɣ (Th1), IL-17 (Th17) and IL-4 (Th2). Data are 
means ± SD (n=6). 
Results and discussion 
 
48 
 
Figure 6. Treg subpopulations in the 
lamina propria. Percentage of Tregs 
(CD25high Foxp-3+) in the CD4+ and 
CD8+ subpopulations of colonic LP CD45+ 
infiltrate. Data are means ± SD (n = 12 
mice). 
 
   
The local cellular, microbiological and cytokine milieu affect the  
immunophenotype and function of Tregs. Indeed, the homeostasis and control of colitis 
depends on the presence of the immunosupresive cytokines IL-10 and TGF-β, both 
produced by Tregs. IBDs models are accompanied by the accumulation of dendritic 
cells in the mesenteric lymph nodes as well as locally in the colon. As it was previously 
reported, the stimulation of PSGL-1 on the DCs with P-selectin enhance the generation 
of tolerogenic T cells. Then, it is probably that reduction of CD25high Foxp-3+ T cell is 
due to the disrupted tolerogenic program of the DCs when PSGL-1 signaling is absent. 
It is also feasible that the relative low proportion of Tregs observed in PSGL-1 
KO mice may be enough to limit the proliferation of Th1, Th2 and Th17 effector cells 
under steady state conditions (Asseman et al, 1999; Asseman et al, 2003), preventing an 
spontaneous colitis. In this regard, it is also possible that the impaired leukocyte 
recruitment in PSGL-1-/- mice may prevent the immune surveillance and therefore 
PSGL-1 would contribute to control the response to commensal microbiota. 
 
4.1.4 Experimental colitis induced by DSS in PSGL-1 deficient mice 
 To assess the influence of the altered gut homeostasis of PSGL-1 deficient mice 
on the initiation and progression of inflammatory bowel disease, we used the dextran 
sulfate sodium salt (DSS) induced colitis model. Addition of 4% DSS to drinking water 
causes acute disease with severe clinical and histological symptoms (Cooper et al, 
1993).  Clinical symptoms started earlier in PSGL-1-/- mice (Figure 7A and B). 
Examination of disease induced by 4% DSS showed that the disease progressed faster 
and was more severe in PSGL-1-/- mice: at day 5 of treatment KO mice had lost on 
average 20% of their initial weight (Figure 7A), had a high disease activity index 
(D.A.I.) (Figure 7B) and showed more severe colon inflammation than WT (Figure 7C). 
Results and discussion 
 
49 
 
 
 
 
 
 Moreover, three out of the 16 KO mice died on day 5 before the completion of 
analysis. Histological analysis showed that the colons of PSGL-1-/- mice were more 
distended and showed greater infiltration and a higher extent of crypt destruction than 
WT (Figure 8). These results indicate that PSGL-1 deficient mice initiate colitis earlier 
and develop a more severe disease than WT mice. 
 
 
 
 
 
 
 
Figure 8. Histologic analysis of disease severity.  Hematoxylin/Eosin staining of sections of 
colon obtained after 5 days treatment with 4% DSS. 
Figure 7. Progression of acute colitis induced by DSS in PSGL-1-/- mice. Acute colitis was induced 
in WT and PSGL-1 KO mice by including 4% DSS. A) Percentage of the initial weight from day 0 at 
day 5 of 4% DSS treatment. Data are means ± SD (n=5 mice) from a representative experiment of 
three; * p<0.05. B) Time course of disease activity index (DAI), scored by clinical symptoms (see 
Methods). C) Representatives images of colon obtained after 5 days of treatment with 4% DSS. 
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4.1.5 Profile analysis of inflammatory immune cell populations in colonic LP 
affected by chemically induced colitis 
  
We analyzed the colonic inflammatory cell infiltrate induced by DSS treatment. As 
shown in Figure 9, a diminished number of DCs and macrophages was observed in the 
inflammatory cell infiltrate of PSGL-1-/- mice.  
 
 
 
Concerning the role of PSGL-1 exclusively on T lymphocytes and the 
development of UC,  it has been reported that PSGL-1 deficiency exacerbates the 
development of inflammation in a mouse model of chronic ulcerative colitis (UC) 
induced by the adoptive transfer of naive PSGL-1-/- T cells into RAG-deficient hosts 
(Matsumoto et al, 2009). In fact, they observed that when PSGL-1 is absent, T cell 
enhances their adhesion and proliferative response. Moreover, other study suggested 
that PSGL-1 is not necessary to initiate ulcerative colitis and that the combination of 
other adhesion molecules play a more critical role for T cell trafficking and disease 
pathogenesis (Ostanin et al, 2007). 
Immuno-blockade of PSGL-1 attenuated the established experimental colitis by 
reduction of leukocyte rolling and adhesion (Rijcken et al, 2004). In the same direction, 
Figure 9. Leukocyte infiltrate in the colonic LP of PSGL-1-/- mice after acute colitis induction. 
Cell suspensions were obtained from colons of WT and PSGL-1 KO mice treated with 4% DSS (5 
days). A) Percentage of CD45+ cells in the LP infiltrate and the percentage of Gr1+ cells in the CD45+ 
population. B) Percentage of CD4+ and CD8+ T lymphocytes, B cells (B220+), DC (CD11c+), 
macrophages (F4/80+) and NK cells (DX5+) in the CD45+ population. 
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Figure 10. Expression of activation 
markers in macrophages after DSS 
treatment. Suspensions of F4/80+ cells 
were stained with antibodies for surface 
markers and analyzed by FACS (n=4)  
our results showed a reduction of leukocytes recruitment to the LP when 4RA10 
blocking antibody was injected in WT mice; specifically macrophages, DCs and B cells. 
Accordingly, these populations were reduced in lamina propria under steady state and 
acute colitis induced with DSS in PSGL-1 knockout mice, but significant difference was 
observed neither in the cell number nor the percentage of CD4 and CD8 T cells. These 
results suggest that both models have differences regarding the conditional population; 
cell transfer model of colitis focus only in T cell capacity of proliferation while our DSS 
model reflects the effect of PSGL-1 absence in response to chemical injury of all the 
populations implicated in the establishment of the inflammatory response. However, the 
precise contribution of T cells and myeloid cells remains unknown. 
Regarding the innate immune system, an enhanced proportion of CD8+ NKT 
cells was detected in PSGL-1-/- upon DSS treatment (Figure 9). In addition, 
macrophages showed an increased expression of pro-inflammatory markers Gr1 and 
CD62L and enhanced expression of the activation marker CD69 (Figure 10). 
 
 
 
In spite of the relatively low number of macrophages and DCs in the LP of 
PSGL-1 knockout mice under steady state conditions, these animals rapidly developed 
an aggressive form of colitis upon treatment with DSS, indicating that these mice have 
an enhanced ability to generate innate immune responses (Jurjus et al, 2004), what is in 
agreement with the activated phenotype of the LP macrophages. 
 The analysis of cytokine production showed that the percentages of 
macrophages producing IL-12, IL-4 and IFN-γ were higher in the PSGL-1-/- mice (Fig 
11). In addition, the proportion of IL-10+ DCs was lower in PSGL-1 deficient mice, 
whereas the percentage of IL-4-producing DCs was significantly enhanced (Figure 11).  
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4.1.6 T cell responses in colonic LP during DSS-induced colitis 
We next carried out a multi-cytokine analysis of colon homogenates.  In this 
regard, it has been described that immunogenic DCs and activated macrophages are able 
to synthesize the pro-inflammatory cytokines IL-6 and IL-1, which induce the 
differentiation of Th17 cells (Sonderegger et al, 2008). Interestingly, IL-1α, IL-22 and 
IL-6 levels induced by DSS treatment were markedly higher in the colons of PSGL-1-/- 
mice (Figure 12). 
 
 
 
 
 
Figure 12. Increased inflammatory cytokine levels in the colonic LP of PSGL-1-/- mice after 
acute colitis induction. Colons were obtained from WT and PSGL-1 KO mice treated with 4% DSS. 
Total protein cell lysates were incubated with the antibody cocktail of the Th1/Th2/Th17 Flow 
Cytomix kit and analyzed by FACS. The panel shows the amounts of IL-1α, IL-22 and IL-6 found in 
300 ng total protein (n=12 mice) 
Figure 11. Cytokine profile of innate immune cells in lamina propria in acute colitis. 
Macrophage (left) and dendritic cells (right) subpopulations were analyzed by intracellular 
cytokine staining and FACs. In all cases, data are means ± SD from 6 mice 
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Figure 13. Th responses in the colonic LP of 
PSGL-1-/- mice after acute colitis induction. 
Percentages CD4+ (left) and CD8+ (right) T cells 
expressing IFN-ɣ (Th1), IL-17 (Th17) and IL-4 
(Th2), upper panel.  Percentage of Treg 
(CD25high Foxp-3+) in the CD4+ and CD8+ 
subpopulations, lower panel, (n=6). 
The analysis of T cell populations in LP of DSS treated mice showed an 
enhanced number of IFN-γ and IL-17 producing CD4+ T cells (Th1, and Th17 cells, 
respectively) in PSGL-1 deficient mice (Figure 13 upper panel). Also a higher 
percentage of CD8+ T lymphocytes producing IFN-γ+ and IL-17+.  
 
 
 
 
Despite of an enhanced number of LP effector IFN-γ+ and IL-17+ lymphocytes 
in PSGL-1-/-, these animals showed a similar proportion of Treg cells than WT mice 
(Figure 13 lower panel) which indicate an imbalance in the Treg/Th17 ratio. These data 
further support that PSGL-1 deficient mice have a defective generation of Treg cells 
(Urzainqui et al, 2007a), a phenomenon that very likely contributes to the enhanced 
tissue damage observed upon induction of acute colitis. Thus, it is very likely that in 
PSGL-1 deficient mice, the presence of increased proportion of activated macrophages 
under steady state conditions favors the differentiation of Th17 lymphocytes, in the 
presence of a triggering factor such as DSS. In turn, Th17 lymphocytes would be 
responsible for the observed over-production of IL-22, which along with IL-17 exert an 
important pro-inflammatory effect. Interestingly, recent studies in humans with IBD 
have detected increased levels of IL-17, IL-1 and IL-6 mRNAs in intestinal mucosa and 
a reduced ratio of circulating Treg/Th17 (Eastaff-Leung et al). In fact, these results are 
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in agreement with previous reports in the sense that T cells contribute to the increased 
disease of ulcerative colitis (Matsumoto et al, 2009). Here, in DSS acute colitis in 
PSGL-1 knockout mice, the basal enhanced activation of macrophages and DCs 
together with the reported higher proliferation rate of T cells and the insufficient 
generation of Tregs drives the inflammation in this model. 
Altogether, our findings indicate that PSGL-1 engagement in DCs and 
macrophages is necessary for the regulation of innate immune cell responses as well as 
for the modulation of adaptive T cell responses and the initiation/resolution of 
inflammatory phenomena. We consider that this places PSGL-1 as a novel potential 
target for pharmacological intervention to ameliorate or resolve inflammatory diseases 
such as IBD. 
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4.2 HDAC6: Role at the exocytosis of lytic granules in CD8 T cells  
 
4.2.1 Contribution of HDAC6 to the lytic protein repertoire.  
In order to study the role of HDAC6 in the cytotoxic context we first performed 
a proteomic analysis of enriched microsomal fractions, associated to the centrosome, 
purified from wt and hdac6-/- CTLs by sucrose gradient ultracentrifugation.  We found 
an altered composition in lytic granule-associated proteins in hdac6-/- cells. We detected 
a larger number of peptides for Perforin-1 and Granzymes A (isoform HF2), B, C and 
D; (Figure 14).  
 
 
 
 
 
Since these proteins are up-regulated by CD8 maturation into CTLs (Williams & 
Bevan, 2007), we analyzed the transcription levels of different proteins involved in the 
process (Figure 15). granzyme B showed an up-regulation, a slightly increment occurred 
in perforin-1, while lamp1 and cathepsin D mRNAs showed no differences. eomes 
showed also an up-regulation, which is in accordance with its role in the regulation of 
perforin and granzyme b transcription.  
Figure 14. Proteomic analysis from enriched microsomal fractions. Enriched microsomal fractions 
purified by sequential subcellular fractionation and sucrose gradients from wild-type and hdac6-/- 
mature blast T cells previously activated in vitro and cultured with IL-2 during 12 days. Protein 
abundance (expressed in spectral counts) of a set of selected proteins is shown at the left; for 
comparison the abundances of other control proteins are also shown at the right. 
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In fact, some HDACs have been implicated in the transcriptional regulation of 
these key proteins. HDAC1 deletion, e.g., increased Eomes expression in naïve CD8+ T 
cells at resting, while Prf1 seems to be up-regulated upon activation (Tschismarov et al, 
2014). 
 
4.2.2  HDAC6 deficiency reduces the cytolytic capacity of CD8+ T lymphocytes. 
 HDAC6 regulates the tubulin cytoskeleton through the post-translational control 
of α-tubulin acetylation (Valenzuela-Fernandez et al, 2008). To ascertain its role in 
CD8+ T cells, we examined the ability of cytotoxic T cells from hdac6-/- mice to kill 
target cells in vitro. Naïve CD8+ T cells from wild-type (WT) and hdac6-/- mice 
expressing the transgenic OVA-specific TCR receptor (OT-I) were stimulated with 
OVA257-264 (100 nM) and cultured for at least 7 days in presence of IL-2 to generate 
activated CTLs. Cell cytotoxicity was subsequently analyzed by survival of dye-labeled 
target cells pulsed or not with OVA257-264 peptide. hdac6-/- CTLs showed decreased 
killing activity at every target: CTL ratio tested (Figure 16A); this effect was also 
observed in CTLs from OT-I mice treated with the specific HDAC6 inhibitor tubastatin 
A, although to a lesser extent (Figure 16B).  
Figure 15. Gene expression of cytotoxic genes. The expression of these genes was assessed by qRT-PCR 
of RNA extracts from WT and hdac6-/-  blast T cells, and normalized with β-actin, β2 microglobulin and 
Ywhaz expression (n=3 , from 2 independent experiments). 
Results and discussion 
 
57 
 
Figure 17. HDAC6 deletion decreases Lamp1 
accumulation in membrane. Degranulation is 
shown as the percentage of CD107a+ (lamp1) cells 
detected by flow cytometry in activated vs non-
stimulated WT and hdac6-/- CD8+ CTLs. *, P < 
0.05. EL4 target cells loaded with 500 nM OVA 
peptide (SIINFEKL) that were mixed with OT-I 
WT or hdac6-/- CTLs during 3h in the presence of 
Monensin A (10µM) and CD107a+ Alexa 647 
antibody. 
 
 
 
The decreased cytotoxicity observed does not correlate with the enhanced 
expression of Granzyme B, Perforin and Eomes found when HDAC6 is absent. These 
data point to a potential impairment in the transport and/or secretion process of lytic 
granules, instead of a defect in their biogenesis, since there seem to be enough lytic 
proteins in knockout cells to perform the cytotoxic function. 
 
4.2.3 HDAC6 is required for degranulation in activated CTLs. 
We next investigated the role of HDAC6 in lytic granule secretion by testing for 
the presence of CD107a at the CTL plasma membrane after TCR stimulation. 
Consistently with decreased cytotoxicity, hdac6-/- CTL showed a reduced expression of 
CD107a (lamp1) after 3h of degranulation using the same ratio of target and effector 
cells (Figure 17). 
  
 
Figure 16. HDAC6 is required for cytotoxic activity. Cytotoxic assay showing specific lysis of EL4 
target cells loaded with 500 nM OVA peptide (SIINFEKL) that were mixed with OT-I WT and hdac6-/- 
CTLs (A) (n=5); or CTLs treated with Tubastatin A vs vehicle (B) (n=3). Graphs show mean ± SEM of 
specific lysis for 5 h at the indicated target to effector ratios. All killing assay where performed in 
triplicate. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Statistical analysis: unpaired T-test for OT-I WT 
and hdac6-/- and paired T-test for inhibitor treatment. 
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Then, we assessed the proteins secreted from the lytic granules of CD8+ T cells 
of control and hdac6-/- stimulated with with phorbol 12-myristate 13-acetate (PMA) for 
1 h. We observed that Cathepsin D and Prf1 were decreased in supernatants from 
activated hdac6-/- CTLs (Figure 18).  
 
 
 
 
These results are in correspondence with lower lamp1 (CD107a) surface 
expression. Altogether our data demonstrate that HDAC6 inhibition by genetic or 
chemical means decrease the cytotoxic activity of CTLs, and suggest that HDAC6 may 
control exocytosis.  
 
4.2.4 TCR signaling and IFN-γ production is not altered by HDAC6 absence in 
CTLs.  
T-cell signaling induced by anti-CD3 plus anti-CD28, as determined by PLCγ1 
(Figure 19A) and erk1/2 (Figure 19B) phosphorylation in CD8+ T cells from hdac6-/- 
mice was comparable to control mice. These results suggest that the killing defect 
observed in HDAC6-deficient CTLs does not result from a general impairment of CD8+ 
T cell function.  
Figure 18. HDAC6 regulates the degranulation of CTLs. Exocytosis of lytic mediators is shown by 
western blot. Proteins released to the supernatant and collected in serum free medium are compared to 
the corresponding cell fraction upon PMA stimulation (1 h). A representative experiment is shown for 
mature CD8+ CTLs from WT and hdac6-/-. Tubulin is shown as loading control for endogenous protein 
level. 
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We next tested the role of HDAC6 in the expression of IFN-γ and found that the 
absence of HDAC6 did not affect secretion of IFN-γ and frequency of CTLs producing 
IFN-γ in response to polyclonal stimulation (Figure 20A and B). Likewise, treatment of 
CTLs from OT-I mice with tubastatin A had no significant effect on IFN-γ expression 
and secretion in response to OVA agonist peptide.  
 
 
 
 
 
 
 
 
Figure 19. TCR signaling is conserved in hdac6-/- CTLs. Effector CD8+ CTLs isolated from WT 
and hdac6-/- mice were activated with anti-CD3/anti-CD28 antibodies for the indicated times. Cells 
were lysed and analyzed by western blot. Activation was analyzed by detecting PLCγ1 and erk1/2 
phosphorylation at the indicated residues.   
 
Figure 20. IFN-γ production is conserved in 
HDAC6 knockout CTLs. (A) Graph showing 
the IFN-γ secretion in cell culture supernatants 
from activated WT and hdac6-/- CTLs by ELISA. 
(B) Percentage of IFN-γ positive cells in WT and 
hdac6-/- CTLs activated with anti-CD3/anti-CD28 
antibodies and (C) Percentage of IFN-γ positive 
cells in OTI CTLs treated with vehicle or 
Tubastatin A and activated with specific peptide 
for the indicated time points. 
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4.2.5 Defective in vivo and ex vivo killing in HDAC6 knockout mice 
To assess the effector activity of hdac6-/- CD8+ T cells, we tested their ability to 
kill a specific target cell in vivo following immunization against specific antigens. WT 
and hdac6-/- mice were immunized with bone marrow-derived dendritic cells activated 
with LPS and pulsed with the OVA 257-264 peptide and in vivo killing activity against 
target cells pulsed or not with OVA peptide was analyzed seven days later.   
Notably, hdac6-/- mice showed reduced specific killing of target cells in vivo 
(Figure 21A). However, the frequency of OVA-specific CD8+ T cells from the 
endogenous repertoire was not affected in the absence of HDAC6 (Figure 21B), 
suggesting that the cytotoxic function rather than the number of antigen-specific CTLs 
could underlie the defective killing activity in hdac6-/- mice.  
 
 
 
 
Next, we examined whether the decreased cytotoxic function of hdac6-/- CTLs 
resulted in an impaired ability to prevent morbidity/mortality during a viral infection. 
To restrict HDAC6 deficiency to CD8+ T cells, we adoptively transferred rag1-/- mice 
with WT or hdac6-/- CD8+ T cells and subsequently challenged with a fully replicative 
vaccinia virus (VACV) WR strain. This infection model mimics the immunological and 
clinical features of smallpox vaccination in humans (Mota et al, 2011). The rag1-/- mice 
passively-transferred with hdac6-/- CD8+ T cells showed increased morbidity at days 9 
Figure 21. In vivo killing is impaired when silencing HDAC6. WT and hdac6-/- were 
immunized i.p. using bone marrow derived dendritic cell previously activated with LPS (1µg/ml) 
and loaded with the specific OVA257-264 peptide in order to generate a specific CD8+ CTLs. 7 days 
after immunization, OVA pulsed target cells labeled with cell violet were injected ip, after 24h 
were recovered by intraperitoneal lavage and cell survival was assessed by FACs (A).  Relative 
percentage of CD8+ H-2 Kb+ was determined as a control of avidity towards the OVA peptide (B), 
n=5, pool of 3 independent experiments. *, P < 0.05. 
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and 11 post-infection (p.i.) compared to rag1-/- mice transferred with WT CD8+ T cells 
(Figure 22A).  
 
 
 
 
Virus titration from the lesional tissue demonstrated that hdac6-/- immune cells 
exerted less efficient virus clearance (Figure 22B). The model of infection described by 
(Mota et al, 2011) in rag1-/- mice without cell transfer produced a severe disease, with 
uncontrolled viral replication at the inoculation site and dissemination to internal 
organs. Eventually, these mice reached 100% mortality before the day 20 post infection. 
rag1-/- mice are T and B cell deficient, due to a disruption of the recombination 
activation gene 1, responsible for somatic recombination that occurred in T and B cells 
precursors, but they retain normal levels of population such as macrophages, dendritic 
and natural killer cells. The development of generalized disease implicated disseminated 
poxvirus lesion in the face, forepaw and tail, which culminate in mortality. This 
confirms the essential role of adaptive immune population in host to control the 
replication of VACV in the murine model of scarification.  
Consistent with our findings on the lack of effect in endogenous antigen-specific 
CD8+ T cell numbers, CTL expansion tracked at day 13 p.i. was not affected in the 
absence of HDAC6 (Figure 23, left). The proportion of these cells at early (5 d.p.i) and 
late stages (13-30 d.p.i.) of the disease were similar for WT and hdac6-/- mice (tested in 
peripheral blood or spleen, respectively; Figure 23, right).  
Figure 22. Vaccinia infection disease progression. (A) rag1-/- mice were inoculated intravenously 
with 0.8x106 CD8+ naïve cells; all animals were infected with VACV-WR by tail scarification and 
weighted every 2 days. Graphs represent means. Bars, SEM. **, P < 0.01. (B) Titration of viral 
particles from scarified tails from WT and hdac6-/- mice upon 13 d.p.i. Tissue from tails was 
disaggregated. CV-1 cells were infected in vitro with different dilutions of tissue extracts, fixed and 
stained. Colonies of VACV-infected cells were counted. 
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Figure 24. CD8+ T cell in vivo proliferation. WT and HDAC6-/- CD8 naïve T cell were labeled with 
Cell violet and injected i.v. in CD45.2 receptors, immediately mice were scarified. Expanded CD8 T 
cells were recovered at day 4, n=5.  * P < 0.05. 
 
 
 
 
 
Independently, we tested the in vivo hdac6-/- CD8+ T cell proliferation using a 
OTI- OVA system. WT mice were injected in the foothpath with a WW-VACV 
(vaccinia virus specific for a OVA peptide); then labeled naïve CD8+ T cell from WT 
and hdac6-/- OT-I mice were transferred i.v. The proliferation rate was comparable, or 
even increased (division 4) in hdac6-/- compared to WT (Figure 24). 
 
 
 
 
 
 
 
 
Figure 23. CD8+ T cell in vivo proliferation. Percentage of CD8+CD44+ isolated from blood (5 
d.p.i.) and spleen (13 and 30 d.p.i.) of Rag1-/- mice and analyzed by FACs. CD11b was used as 
negative control, n=5. 
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By contrast, in vivo assays using hdac6-/- CD8+ T cells in response to a different 
viral infection model like LCMV (lymphocytes choriomeningitis virus strain) infection 
showed similar results of hdac6-/- CD8+ T cell respect to WT (data not show). Our 
hypothesis is that this phenotype is due, in part, to a compensatory effect probably 
coming from other histone deacetylase and to the specific activation of other members 
of the family . In fact, reports studying HDAC1 showed a deficient differentiation of 
effector CD8+ T cell and a reduced anti-viral response upon LCMV infection and 
impaired expansion. In vitro, CTLs were largely unaffected and this has been attributed 
to a compensatory effect from another member family of deacetylase like HDAC2 
which partially compensates for loss of HDAC1 and thus mask potential functional 
consequences of HDAC1 deletion (Tschismarov et al, 2014). Thus, it is likely that this 
HDAC I family member partially compensates for loss of HDAC6 and thus masks 
potential functional consequences of HDAC6 deletion. These in vivo results emphasize 
the role of HDAC6 in the CD8+ T cell-dependent protection against Vaccinia virus 
infection. The differentiation of effector CD8+ CTLs seems to be unaffected by HDAC6 
deficiency, since the proliferation rate and cell proportions are similar to wild type.  
 
4.2.6 Impairment at the late stage of lytic granule exocytosis 
CTL killing is limited to target cells (and not neighbor cells) by the confinement 
of secretion to the immune synapse that is established between the CTL and the target 
cell (de Saint Basile et al, 2010). Interestingly, perforin and lamp1 (CD107a) 
intracellular co-localization was affected in hdac6-/- CTLs conjugated with target cells, 
pointing to a de-regulated localization of perforin in these cells (Figure 25; images and 
lower graphs). This corresponds with the decreased secretion of lytic proteins in 
response to PMA in the hdac6-/- CTLs and suggests that HDAC6 regulates exocytosis of 
lytic granules (Figure 18).  
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4.2.7 Efficient MTOC translocation in hdac6-/- CTLs   
Defects in lytic granule polarization to the contact are with the target cell could 
be explained by a impaired MTOC translocation. However, the efficient translocation of 
centrosome to the contact area with the target cell observed in hdac6-/- CTLs (Figure 26) 
suggests that the defective exocytosis may rely on the movement of granules 
themselves.  
Figure 25. CD107a and Perforin co-localization upon conjugate formation. Images from confocal 
microscopy of CTLs derived from WT and hdac6-/- OT-I mice and conjugated with CMAC cell 
tracker-loaded, OVA pre-pulsed target cell EL4 (500 nM SIINFEKL, Cyan). Conjugate formation was 
allowed for 15 min and cells were fixed, permeabilized and stained with anti-CD107a, anti-perforin 
(green and red, respectively; left panel) and α-tubulin (magenta; right panel) antibodies. Fluorescence 
images correspond to maximal projections of equal number of slices from confocal Z-stacks. BF 
images correspond to a unique plane. Scale bar, 4 µm. Lower graphs show the co-localization of 
Lamp1 (CD107a) and Perforin1 in cells (n= 35 cells for WT and hdac6-/- CTLs).  *, P < 0.05; **, 
P<0.01; Mann-Whitney test. 
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Figure 26. MTOC distance to APC. 
Quantification of MTOC translocation, 
shortest distance of MTOC to the APC 
surface in the contact area (n>270 from 3 
independent experiments); *, P < 0.05. 
Unpaired T-test. 
Figure 27. Representative TIRFm images 
of Lysotracker red-loaded CTLs. CD8+ 
CTLs from WT and hdac6-/- mice were 
allowed to settle on anti-CD3/anti-CD28-
coated glass-bottom chambers maintained at 
37ºC and 5% CO2. Video recording was 
initiated upon cell adhesion with the 
stimulating surface.  Images were acquired 
for 5 min every 0.5 s at 90 nm of penetrance 
with 561 nm laser excitation. Scale bar, 4 µm 
 
This is in accord with previous studies described the lack of effect on MTOC 
polarization upon immune synapse in CD4+ T cells when were treated with TSA, while 
the HDAC6 over-expression prevented its polarization (Serrador et al, 2004).   
 
4.2.8 Critical role of HDAC6 in the lytic granule release.  
We thus monitored the dynamics of granule release by Total Internal Reflection 
Fluorescence microscopy (TIRFm). Cells were loaded with a pH-dependent, lysosomal 
tracker that allows the visualization of the lysosomal-related lytic granules. The CTLs 
were allowed to settle on an anti-CD3 + anti-CD28-coated surface. CTLs form an IS-
like structure in which the dynamics of lytic granules can be tracked at the intracellular 
proximal region beneath the plasma membrane (Figure 27). 
 
 These experiments revealed significant changes in the distribution of the lytic 
granules and their dynamics, with a marked decrease in the number of lytic granules 
detected at the IS-like in hdac6-/- suggesting alterations to the active transport of the 
granules from the centrosomal region to the plasma membrane. Indeed, the mean 
fluorescence intensity detected for hdac6-/- granules was lowered, which suggests a 
higher pH and therefore a different degree of maturation, although the lytic granules 
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displayed similar sizes in WT and hdac6-/- (Figure 28A). 
 
 
 
 
The most remarkable difference pertained to the xy distribution of the lytic 
granules, which was wider (diffusion surface) in the hdac6-/- CTLs, therefore showing 
enlarged diffusion coefficient maintaining similar duration times and paths length 
(Figure 28B). These data suggest that the lytic granules from hdac6-/- CTLs are not 
properly targeted to the contact with the target cell and dock deficiently at the plasma 
membrane. 
 
4.2.9 HDAC6 binds kinesin-1 motor and links dynactin complex subunits 
Tubulin motors control the delivery of lytic granules to the plasma membrane. 
Whereas dynein controls granule targeting to the centrosome (Burkhardt et al, 1993), 
kinesin-1 together with Slp3/Rab27a directs terminal transport to the plasma membrane 
for exocytosis  (Kurowska et al, 2012). In this report Slp3 acts as an effector of Rab27a 
during the terminal process of exocytosis in cytotoxic T lymphocytes, and forms a 
complex with kinesin-1 through binding to the tetratricopeptide repeat of the light chain 
subunit (KLC1). This complex is a determinant step for polarized lytic granules to reach 
de membrane (docking) and eventually release their content at the immune synapse. In 
fact, it has been previously proposed that for the terminal step of lytic granules 
exocytosis, they must undergo a maturation step via the fusion of lytic granules with an 
Figure 28. Dynamics quantification of lytic granules. The number of lytic granules, area of particles 
(size), path length, duration (time) (A) and diffusion surface, diffusion coefficient and mean 
fluorescence intensity (B), at the IS-like was quantified for each cell. n=28 cells of each genotype were 
analyzed for the entire time-lapse from 3 independent experiments. 
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endosomal compartment bearing Rab27a, Munc13-4, and Slp exocytic effectors 
(Menager et al, 2007). This occurs once both type of organelles have been brought close 
to the immune synapse, which support the idea of Rab27a-Slp3–kinesin-1 complex 
acting in the terminal transport once lytic granules have acquired the exocytic 
machinery. 
Dynactin may also be part of this complex, linking the cargo to kinesin-1 motor, 
thereby powering vesicles towards the plus end of microtubules (Haghnia et al, 2007; 
Hendricks et al, 2010). There is a debate of whether α-tubulin Lys-40 acetylation 
directly mediated the transport and velocity of Kinesin-1 to the microtubule track. First, 
it has been reported that the loss of α-tubulin acetylation at Lys-40 influences in the 
biding and motility of kinesin-1 in cultured neuronal cells (Reed et al, 2006). Second, 
by comparing the kinesin velocity and affinity to the track on microtubules reconstituted 
from acetylated and deacetylated porcine tubulin, it was observed  that tubulin 
acetylation alone does not affect kinesin-1 motility (Walter et al, 2012). 
We hypothesized then, that HDAC6 may regulate the movement and delivery of the 
lytic granules at the IS through a direct kinesin-1 interaction. Using a biochemical 
approach, we observed that HDAC6 formed a complex with kinesin-1 light chain 
(KLC1) when cells were triggered with anti-CD3 + anti-CD28 (Figure 29A). 
 
 
 
Figure 29. Western blots showing co-immunoprecipitation of transport complexes. Cell lysates of 
resting or anti-CD3+anti-CD28-activated WT and hdac6-/- mature CD8+ CTLs (15 min). Antibodies 
anti-kinesin light chain 1 subunit from kinesin complex (KLC1) or anti-p150 glued subunit from 
dynactin complex (p150) were used. Immunoprecipitates were processed and blotted against anti-
KLC1 and HDAC6 (A) or p150 and p50 dynamitin subunits from dynactin complex (B) antibodies. 
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Moreover, interaction of the kinesin-activator complex dynactin subunits p150-
glued and p50-dynamitin was impaired in the absence of HDAC6 in T cells (Figure 
29B).  
It has been described, in NK cells, that myosin IIA facilitates lytic granule transit 
through the F-actin-rich area in the surrounding of the immune synapse (Andzelm et al, 
2007). This evidence together with the fact that the strength of TCR dictates the path the 
lytic granules take to position within the immune synapse suggest that, depending on 
the signaling strength, kinesin-1 and myosin IIA play distinct role in directing lytic 
granules transport to secretion sites. The possibility that Kinesin-1 and/or its association 
with dynactin could be tuned by HDAC6 underscores this interaction as a possible 
regulator of the recently described kinesin-1/Slp3/Rab27a complex that mediates transit 
step to membrane. 
In summary, our data support a specific role for HDAC6 in the intracellular 
localization of lytic mediators and, particularly, in the process of their secretion. 
Therefore, the catalytic and scaffold activities of HDAC6 may act at multiple levels in 
the control of cytotoxic-related pathways and make HDAC6 a potential candidate to 
target CTLs in specific diseases, as a therapeutic strategy. 
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5. CONCLUSIONS 
 
1 PSGL1-/- mice show an altered distribution of leukocyte subpopulations in the 
lamina propria at steady state, with decreased proportion of innate immune cells 
(DCs, macrophages and NKs). 
2 The cytokine profile and pro-inflammatory phenotype of myeloid and T cells 
support a role for PSGL-1 on the regulation of the balance between tolerance 
and immunity. 
3 PSGL-1 tolerogenic role in DCs and macrophages is confirmed in vivo by 
administration of 4RA10 antibody that reduces the MHC-II expression in these 
populations, acting as an agonist of P-selectin.  
4 PSGL-1-/- mice develop an earlier and exacerbated colitis induced by DSS 
treatment in accordance with the unbalance proportion of Treg/T effector cells at 
the previous steady state. 
5 HDAC6 deficit alters the gene expression of cytotoxic proteins and impairs the 
cytolytic capacity of CD8+ T lymphocytes by affecting the secretion of lytic 
granules. 
6 Activation of CD8+ T cells and IFN-γ secretion the TCR in the absence of 
HDAC6 were comparable to WT. 
7 CD8+ HDAC6-/- T cells have a reduced ability to prevent morbidity/mortality 
during viral infection in Rag1-/- mice when infected with vaccinia virus.  
8 Granule number, intensity and spreading at the proximal region to the plasma 
membrane are altered in CTLs in the absence of HDAC6. 
9 HDAC6 interacts with kinesin-1 light chain and dynactin complex to properly 
transport lytic granules to their terminal secretion domain in order to complete 
exocytosis. 
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